AMR Research ARTICLE 15682-The New CPG and Life Sciences Business P
AMR Research ARTICLE 15682-The New CPG and Life Sciences Business P
Looking at the title of this article, you may well ask yourself, well, what is new? For most Consumer Packaged
Goods (CPG) and Life Science manufacturing companies, the priority has always been Supply Chain Management
(SCM) and the customer has always been king. The difference is that in most companies SCM is forecasted
back-end business capacity planning, including manufacturing operations, supply chain planning, and execution.
Considerable investments made in products to support SCM from SAP, Manugistics, and i2 Technologies
improved some areas, such as logistics and transportation, warehousing, demand planning, and manufacturing
execution, but didn’t do much for overall business performance as measured by stock outs and perfect order at
the customer side. It’s “the Moment of Truth” as one leading manufacturer refers to it.
What to do?
Plotting the roadmap and incrementally building the consumer demand-driven supply network requires that
manufacturers address the following:
Build mutually beneficial relationships with retailers to share information and synchronize planning
activities such as AMP management
Mine consumer and industry data to understand consumer demand
Segment the supply chain channels and manage inventory for optimum consumer service and loyalty
performance
Build the right supply network--including the supply side component-- to prevent stock outs and replenish
on demand
Effectively minimize the time to peak sales for new products
Build agile, same-day manufacturing execution capabilities with minimal variability in order to meet
customer demand
Comply with regulatory requirements such as product and consumer safety
Integrate IT applications for synchronized business processes that connect customer demand to business
execution
Introduce Radio Frequency Identification (RFID) technology into the supply chain
The answer is, not really. Replace consumer with patient, make-to-demand with replenish-on-demand,
distributors versus wholesalers, 27.5 months to launch a product versus 10 years, add clinical trials, significantly
increase regulatory compliance requirements and then take a look at the two supply chains. Similarities include
segmented channels, inventory visibility, the need for communities, and supply chain network, which lead to
similar strategies and challenges. The software vendors are different because of regulatory compliance issues.
The overarching point is that the modern CPG and Life Sciences supply chain is based on customer or patient
pull, and the ability to meet customer demand puts a company on the starting block. Even if you think you
make to stock and analyze the impact of demand on your operations, you will see that demand and inventory
visibility have more value than forecasts.